{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "POSTPOST", "regularMarketPrice": 1.07, "exchange": "PAR", "shortName": "ONCODESIGN PRECISION MEDICINE", "longName": "Oncodesign Precision Medicine Soci\u00e9t\u00e9 anonyme", "messageBoardId": "finmb_1793227359", "exchangeTimezoneName": "Europe/Paris", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "fr_market", "esgPopulated": false, "regularMarketChangePercent": -0.46511582, "firstTradeDateMilliseconds": 1664953200000, "priceHint": 4, "regularMarketChange": -0.004999995, "regularMarketTime": 1683874823, "regularMarketDayHigh": 1.07, "regularMarketDayRange": "1.07 - 1.07", "regularMarketDayLow": 1.07, "regularMarketVolume": 1, "regularMarketPreviousClose": 1.075, "fullExchangeName": "Paris", "regularMarketOpen": 1.07, "averageDailyVolume3Month": 7719, "averageDailyVolume10Day": 9144, "fiftyTwoWeekLowChange": 0.45000005, "fiftyTwoWeekLowChangePercent": 0.72580653, "fiftyTwoWeekRange": "0.62 - 2.5", "fiftyTwoWeekHighChange": -1.43, "fiftyTwoWeekHighChangePercent": -0.57199997, "fiftyTwoWeekLow": 0.62, "fiftyTwoWeekHigh": 2.5, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.39, "sharesOutstanding": 16585000, "fiftyDayAverage": 1.150388, "fiftyDayAverageChange": -0.08038795, "fiftyDayAverageChangePercent": -0.06987899, "twoHundredDayAverage": 1.3140445, "twoHundredDayAverageChange": -0.24404442, "twoHundredDayAverageChangePercent": -0.18572006, "marketCap": 17745950, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "prevName": "Oncodesign Precision Medicine (OPM)", "nameChangeDate": "2023-05-11", "tradeable": false, "cryptoTradeable": false, "symbol": "ALOPM.PA"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "18 rue Jean Mazen", "city": "Dijon", "zip": "21000", "country": "France", "phone": "33 380 788 260", "website": "https://opm.oncodesign.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Oncodesign Precision Medicine (OPM), a biopharmaceutical company, engages in the precision medicine business. It offers diagnostic and therapeutic solutions for resistant and metastatic cancers. The company is based in Dijon, France. As of October 19, 2022, Oncodesign Precision Medicine Soci\u00e9t\u00e9 anonyme operates as a subsidiary of Edmond de Rothschild Equity Strategies Management III S.\u00e0.r.l.", "companyOfficers": [], "maxAge": 86400}}], "error": null}}